Literature DB >> 24692266

Chemoradiation therapy for squamous cell carcinoma of the external auditory canal: A meta-analysis.

Yukinori Takenaka1, Hironori Cho1, Susumu Nakahara1, Yoshifumi Yamamoto1, Toshimichi Yasui1, Hidenori Inohara1.   

Abstract

BACKGROUND: The standard treatment for advanced external auditory canal squamous cell carcinoma (SCC) is subtotal temporal bone resection and postoperative radiation therapy (RT), whereas chemoradiation therapy (CRT) is used in some institutions to improve patient prognosis. The purpose of this study was to evaluate the efficacy of CRT in external auditory canal SCC treatment.
METHODS: Meta-analyses of external auditory canal SCC studies were performed. We extracted 5-year overall survival rates and number of patients for aggregate patient data, and types of treatment and outcomes for individual patient data.
RESULTS: The 5-year overall survival rate of 752 patients was 57%. In the individual patient data meta-analysis, the 5-year overall survival rates of patients who received surgery ± RT, preoperative CRT, definitive CRT, and postoperative CRT were 53.5%, 85.7%, 43.6%, and 0%, respectively.
CONCLUSION: Our data suggest that preoperative CRT may improve the survival of surgically treated patients with external auditory canal SCC and that definitive CRT may be equivalent to surgical resection.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  chemoradiation therapy; complication; external auditory canal; squamous cell carcinoma; surgery

Mesh:

Year:  2014        PMID: 24692266     DOI: 10.1002/hed.23698

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  22 in total

1.  Long-Term Outcomes of Patients with Squamous Cell Carcinoma of the Temporal Bone after Concomitant Chemoradiotherapy.

Authors:  Kiyoto Shiga; Katsunori Katagiri; Daisuke Saitoh; Takenori Ogawa; Kenjiro Higashi; Hisanori Ariga
Journal:  J Neurol Surg B Skull Base       Date:  2018-05-14

2.  Survival impact of local extension sites in surgically treated patients with temporal bone squamous cell carcinoma.

Authors:  Go Omura; Mizuo Ando; Yuki Saito; Osamu Fukuoka; Ken Akashi; Masafumi Yoshida; Akinobu Kakigi; Takahiro Asakage; Tatsuya Yamasoba
Journal:  Int J Clin Oncol       Date:  2017-01-02       Impact factor: 3.402

3.  Primary definitive radiotherapy with or without chemotherapy for squamous cell carcinoma of the temporal bone.

Authors:  Yosuke Kitani; Akira Kubota; Madoka Furukawa; Kaname Sato; Yuko Nakayama; Tetsuo Nonaka; Nobutaka Mizoguchi
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-31       Impact factor: 2.503

Review 4.  Temporal bone carcinoma: a first glance beyond the conventional clinical and pathological prognostic factors.

Authors:  Gino Marioni; Alessandro Martini; Niccolò Favaretto; Sebastiano Franchella; Rocco Cappellesso; Filippo Marino; Stella Blandamura; Antonio Mazzoni; Elisabetta Zanoletti
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-10-30       Impact factor: 2.503

5.  Expression of p53, p16, cyclin D1, epidermal growth factor receptor and Notch1 in patients with temporal bone squamous cell carcinoma.

Authors:  Shinya Morita; Yuji Nakamaru; Akihiro Homma; Shinichiro Yasukawa; Hiromitsu Hatakeyama; Tomohiro Sakashita; Satoshi Kano; Atsushi Fukuda; Satoshi Fukuda
Journal:  Int J Clin Oncol       Date:  2016-08-03       Impact factor: 3.402

Review 6.  Temporal bone resection for lateral skull-base malignancies.

Authors:  Gautam U Mehta; Thomas J Muelleman; Derald E Brackmann; Paul W Gidley
Journal:  J Neurooncol       Date:  2020-02-27       Impact factor: 4.130

7.  Comparison of the University of Pittsburgh staging system and the eighth edition of the American Joint Committee on Cancer TNM classification for the prognostic evaluation of external auditory canal cancer.

Authors:  Shinya Morita; Takatsugu Mizumachi; Yuji Nakamaru; Tomohiro Sakashita; Satoshi Kano; Kimiko Hoshino; Atsushi Fukuda; Keishi Fujiwara; Akihiro Homma
Journal:  Int J Clin Oncol       Date:  2018-07-05       Impact factor: 3.402

8.  Temporal bone carcinoma: Treatment patterns and survival.

Authors:  Kristen L Seligman; Daniel Q Sun; Patrick P Ten Eyck; Nathan M Schularick; Marlan R Hansen
Journal:  Laryngoscope       Date:  2019-03-15       Impact factor: 3.325

9.  Management of lateral skull base cancer: United Kingdom National Multidisciplinary Guidelines.

Authors:  J J Homer; T Lesser; D Moffat; N Slevin; R Price; T Blackburn
Journal:  J Laryngol Otol       Date:  2016-05       Impact factor: 1.469

10.  Prognostic significance of inflammatory response markers for locally advanced squamous cell carcinoma of the external auditory canal and middle ear.

Authors:  Kenji Makita; Yasushi Hamamoto; Noriko Takata; Hirofumi Ishikawa; Shintaro Tsuruoka; Kotaro Uwatsu; Naohito Hato; Teruhito Kido
Journal:  J Radiat Res       Date:  2021-07-10       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.